Search For a Provider Facebook Twitter Instagram YouTube ES View the Patient Toolkit

News

Testosterone Therapy Impedes Diabetes Progress, Study Finds

Mar 26, 2019

Testosterone Therapy Impedes Diabetes Progress, Study FindsTestosterone therapy might slow down the path to type 2 diabetes in some men, experts report in Diabetes Care.

The finding applies to men who have both prediabetes and low testosterone.

People with prediabetes have higher-than-normal blood sugar levels, but these levels are not high enough for an official diabetes diagnosis. However, prediabetes increases a person’s risk for type 2 diabetes as well as heart disease and stroke.

Prediabetes can be a wake-up call. People with prediabetes may be able to lower their risk for more serious health conditions by making healthier lifestyle choices.

Men with testosterone deficiency (hypogonadism) are also at higher risk for type 2 diabetes.

The study involved 316 men with prediabetes, low testosterone levels (less than or equal to 12.1 nmol/L), and symptoms of hypogonadism, which may include low sex drive, fatigue, moodiness, and decreased muscle mass.

Two hundred twenty-nine men received testosterone therapy; the remaining 87 men received no treatment. For eight years, the researchers assessed the men’s health twice annually.

1 2 Next » (page 1 of 2)